Chimeric antigen receptor (CAR)-T cell therapy for solid tumors in pediatric patients: current breakthroughs, dilemmas, and strategies
Recent advances, persistent challenges, and emerging strategies for CAR-T cell therapy in pediatric solid tumors are summarized and rational combination strategies involving CAR-T cell therapy with chemotherapy, radiotherapy, and immune checkpoint inhibitors aimed at improving therapeutic efficacy and safety are discus...